{"id":25070,"date":"2022-07-26T07:26:50","date_gmt":"2022-07-26T07:26:50","guid":{"rendered":"https:\/\/celonpharma.com\/?p=25070"},"modified":"2022-07-26T07:26:51","modified_gmt":"2022-07-26T07:26:51","slug":"current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/","title":{"rendered":"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Current report No. 22\/2022<br>Date prepared: 18\/07\/2022<br>Abbreviated name of the issuer: CELON PHARMA S.A.<br>Subject: Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading<br>Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<br>Content of the report:<br>The Management Board of Celon Pharma S.A. (the \u201cCompany\u201d) hereby announces that on July 18, 2022 the Central Securities Depository of Poland (\u201cKDPW\u201d) made a decision to assimilate 5,000 ordinary C-series bearer shares on July 22, 2022, registered under the ISIN PLCLNPH00080 code, with the Company\u2019s shares in the stock exchange trading, registered under the PLCLNPH00015 code.<br>Therefore, the condition for the introduction of the aforementioned 5,000 C series shares to trading on the primary market, specified in the Resolution of the Management Board of the Warsaw Stock Exchange, of which the Company informed in its current report No. 21\/2022 of July 15, 2022, has been met.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Current report No. 22\/2022Date prepared: 18\/07\/2022Abbreviated name of the issuer: CELON PHARMA S.A.Subject: Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange tradingLegal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/\" title=\"ReadCurrent report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[46],"tags":[],"class_list":["post-25070","post","type-post","status-publish","format-standard","hentry","category-current-reports"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Current report No. 22\/2022Date prepared: 18\/07\/2022Abbreviated name of the issuer: CELON PHARMA S.A.Subject: Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange tradingLegal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodicalRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-26T07:26:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T07:26:51+00:00\" \/>\n<meta name=\"author\" content=\"Paulina Dobies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paulina Dobies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/\"},\"author\":{\"name\":\"Paulina Dobies\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"headline\":\"Current report No. 22\\\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading\",\"datePublished\":\"2022-07-26T07:26:50+00:00\",\"dateModified\":\"2022-07-26T07:26:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/\"},\"wordCount\":185,\"articleSection\":[\"Current reports\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/\",\"name\":\"Current report No. 22\\\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2022-07-26T07:26:50+00:00\",\"dateModified\":\"2022-07-26T07:26:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current report No. 22\\\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\",\"name\":\"Paulina Dobies\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/","og_locale":"en_US","og_type":"article","og_title":"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading - Celon Pharma","og_description":"Current report No. 22\/2022Date prepared: 18\/07\/2022Abbreviated name of the issuer: CELON PHARMA S.A.Subject: Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange tradingLegal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodicalRead more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/","og_site_name":"Celon Pharma","article_published_time":"2022-07-26T07:26:50+00:00","article_modified_time":"2022-07-26T07:26:51+00:00","author":"Paulina Dobies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paulina Dobies","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/"},"author":{"name":"Paulina Dobies","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"headline":"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading","datePublished":"2022-07-26T07:26:50+00:00","dateModified":"2022-07-26T07:26:51+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/"},"wordCount":185,"articleSection":["Current reports"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/","url":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/","name":"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2022-07-26T07:26:50+00:00","dateModified":"2022-07-26T07:26:51+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/current-report-no-22-2022-decision-of-the-central-securities-depository-of-poland-kdpw-on-assimilation-of-5000-c-share-actions-with-the-companys-share-in-the-stock-exchange-trad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Current report No. 22\/2022 \u2013 Decision of the Central Securities Depository of Poland (KDPW) on assimilation of 5,000 C share actions with the Company\u2019s share in the stock exchange trading"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b","name":"Paulina Dobies"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/25070","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=25070"}],"version-history":[{"count":1,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/25070\/revisions"}],"predecessor-version":[{"id":25071,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/25070\/revisions\/25071"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=25070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=25070"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=25070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}